Somnia Therapeutics is a patient-centric biotechnology company developing an oral therapy for the treatment of obstructive sleep apnea (OSA), a widespread public health issue affecting more than 10% of adult Americans.
Current treatments are uncomfortable and/or invasive, resulting in low patient compliance or adoption, leaving the majority of patients untreated. At Somnia, we are taking an innovative approach to this largely unmet medical need, providing an easily adaptable and accessible treatment — taking a pill at bedtime.
Are you troubled by loud snoring, feeling tired when you wake up, daytime sleepiness? Have you had enough of CPAP machines? Are you concerned about your overall daytime well-being?
Research has shown that an improvement of Obstructive Sleep Apnea (OSA) during the night reduces daytime sleepiness and helps you feel more productive throughout your day.
Although a small percentage of the adult population is affected by sleep apnea, the number of affected individuals is huge. When we include friends and family, we are all affected.